Related Experiment Videos
The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine
Cancer Research
|February 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides.
International journal of oncology·2001
Antitumor activity and toxicity of novel nitroheterocyclic phosphoramidates.
Journal of medicinal chemistry·2001
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers.
Cancer chemotherapy and pharmacology·1994
XB596, a promising bis-naphthalimide anti-cancer agent.
Anti-cancer drugs·1993
KDM6 Histone Demethylases Tune Pancreatic Cancer Plasticity.
Cancer research·2026
Macroprolactinoma with an atypical course.
Endokrynologia Polska·2026
p38γ and p38δ MAP kinases in inflammation.
Biochemical Society transactions·2026
Optimal Dosing Strategies for Remimazolam Across Diverse Patient Populations: A Clinical Narrative Review.
Drug design, development and therapy·2026
CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine.
Journal of molecular and cellular cardiology plus·2026
Correction: Indobufen-based dual antiplatelet therapy in patients undergoing PCI: a systematic review and meta-analysis.
Frontiers in pharmacology·2026